Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA3 | P07451 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30096741 | 1.00 | GPR84 (0.31) | GPR84CA1CA2CA3CA9 | |
| SCHEMBL14129494 | 0.93 | CA1 (0.32) | CA1CA2CA3CA9 | |
| SCHEMBL19001649 | 0.89 | CA1 (0.31) | CA1CA2CA3CA9 | |
| SCHEMBL4138790 | 0.85 | GPR84 (0.33) | GPR84CA1CA2CA3CA9 | |
| SCHEMBL1191944 | 0.76 | KDM1A (0.34) | CA1CA2CA3CA9 | |
| SCHEMBL12583448 | 0.76 | TTR (0.33) | — | |
| SCHEMBL21614392 | 0.76 | CA3 (0.40) | CA1CA2CA3CA9 | |
| SCHEMBL20828625 | 0.76 | — | — | |
| SCHEMBL12378577 | 0.76 | ALDH1A1 (0.43) | GPR84 | |
| SCHEMBL5174339 | 0.76 | KDM1A (0.39) | CA1CA2CA3CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102153559-B | Method for synthesizing sitagliptin phosphate and derivatives thereof | NANJING UNIVERSITY OF TECHNOLOGY | 2013-04-24 | — | — | CN | claimed |
| CN-102153559-A | Novel method for synthesizing sitagliptin phosphate and derivatives thereof | NANJING UNIVERSITY OF TECHNOLOGY | 2011-08-17 | — | — | CN | claimed |
| EP-1362860-B1 | Method for producing tetrakis (fluoraryl)borate magnesium compound | NIPPON CATALYTIC CHEM IND (JP) | 2010-09-15 | — | — | EP | claimed |
| US-7205441-B2 | Method for producing tetrakis (fluoroaryl) borate-magnesium compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2007-04-17 | — | — | US | claimed |
| US-20030216598-A1 | Method for producing tetrakis ( fluoroaryl) borate-magnesium compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2003-11-20 | — | — | US | claimed |
| EP-1362860-A1 | Method for producing tetrakis (fluoroaryl) borate magnesium compound | Nippon Shokubai Co., Ltd. (JP) | 2003-11-19 | — | — | EP | claimed |
| CN-119604290-A | Compounds for the treatment of coronavirus infections | 特劳斯芬尼德治疗股份有限公司 | 2025-03-11 | — | — | CN | disclosed |
| EP-4186892-A1 | NOVEL COMPOUND, COATING COMPOSITION COMPRISING SAME, ORGANIC LIGHT-EMITTING DEVICE USING SAME, AND MANUFACTURING METHOD THEREFOR | Lg Chem, Ltd. (KR) | 2023-05-31 | — | — | EP | disclosed |
| US-20220402881-A1 | SMALL MOLECULE PROSTAGLADIN TRANSPORT INHIBITORS | ALBERT EINSTEIN COLLEGE OF MEDICINE | 2022-12-22 | — | — | US | disclosed |
| CN-115385919-A | Synthetic method of sitagliptin | 江苏阿尔法药业股份有限公司 | 2022-11-25 | — | — | CN | disclosed |
| EP-3954677-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LG Chem, Ltd. (KR) | 2022-02-16 | — | — | EP | disclosed |
| WO-2021015522-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2021-01-28 | — | — | WO | disclosed |
| EP-3237416-B1 | POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE | GILEAD SCIENCES INC (US) | 2019-05-01 | — | — | EP | disclosed |
| EP-1211255-A2 | Method for producing fluoroaryl metal compound | Nippon Shokubai Co., Ltd. (JP) | 2002-06-05 | — | — | EP | disclosed |
| US-20020065426-A1 | Method for producing fluoroaryl metal compound | NIPPON SHOKUBAI CO., LTD (JP) | 2002-05-30 | — | — | US | disclosed |
| US-6235222-B1 | REACTING, IN SOLVENT CONTAINING CHAIN ETHER SOLVENT, HYDROCARBON MAGNESIUM HALIDE WITH FLUOROARYL HALIDE | NIPPON SHOKUBAI CO., LTD. (JP) | 2001-05-22 | — | — | US | disclosed |
| EP-0995753-A2 | Method for manufacturing fluoroaryl magnesium halide | Nippon Shokubai Co., Ltd. (JP) | 2000-04-26 | — | — | EP | disclosed |
| EP-0109606-B1 | PROCESS FOR THE FORMYLATION OF ARYL HALIDES | BAYER AG (DE) | 1986-01-22 | — | — | EP | disclosed |
| US-4536344-A | USING A PHOSPINE OR PHOSPHITE | BAYER AKTIENGESELLSCHAFT (DE) | 1985-08-20 | — | — | US | disclosed |
| EP-0109606-A1 | Process for the formylation of aryl halides | BAYER AG (DE) | 1984-05-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030216598-A1 | Method for producing tetrakis ( fluoroaryl) borate-magnesium compound | KRAS, MGAM, CA3 | GPR84 3052/4885CA1 190/4885CA2 119/4885 |
| US-20220402881-A1 | SMALL MOLECULE PROSTAGLADIN TRANSPORT INHIBITORS | PTGER1, PTGIS, PTGIR | GPR84 482/4885CA1 2453/4885CA2 526/4885 |
| US-20020065426-A1 | Method for producing fluoroaryl metal compound | DDT, TERT, HACL2 | GPR84 3724/4885CA1 3552/4885CA2 2403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.